Marcelo Ebrard confirms that this Thursday 2 million Doses of Cansino Vaccine will arrive in Mexico

Marcelo Ebrard confirms that this Thursday 2 million Doses of Cansino Vaccine will arrive in Mexico

Marcelo Ebrard, head of the Ministry of Foreign Relations (SRE), reported that this Thursday two million doses of the CanSino vaccine will arrive, this for filling and packaging in Mexico.

Similarly, the Mexican Foreign Minister explained that this antigen will be packaged at the DrugMex Laboratory, located in the Mexican state of Querétaro.

“The authorization of the CanSino and Sinovac vaccines will allow these vaccines to arrive in Mexico soon. For now, tomorrow the first 2 million Cansino will arrive for filling and packaging in Drugmex, Querétaro. Congratulations!”, the official wrote from his Twitter account.

In context, The Ministry of Health (Ssa) confirmed that the Federal Commission for Protection Against Sanitary Risks (Cofepris) gave the authorization for the emergency use of the CanSino and Sinovac vaccines.

Hugo López Gatell, Undersecretary of Prevention and Health Promotion, He explained that the body headed by José Alonso Novelo issued the approval of both vaccines on Tuesday night.

In the first instance, the approval of the CanSino vaccine in Mexico was disseminated through the Financial Times, but no Mexican authority ruled on the matter (Photo: REUTERS)

In the first instance, the approval of the CanSino vaccine in Mexico was disseminated through the Financial Times, but no Mexican authority ruled on it. 

“The CanSino vaccine itself, which by the way has already been granted the emergency registration, the authorization for emergency use, just like the Sinovac vaccine, or Coronavac, which is the brand of the vaccine. Both of Chinese origin ”, declared López Gatell from the National Palace.

In the first instance, the approval of the CanSino vaccine in Mexico was disseminated through the medium Financial Times, but no Mexican authority ruled on the matter.

Thus, during the latest report on the current state of the COVID-19 pandemic in Mexico, the official reported on the approval by the federal agency on Wednesday.

At this news, the authorities verified the incorporation of two more vaccines to the Mexican repertoire of inoculation against the SARS-CoV-2 virus.

Although both vaccines are of Chinese origin, only that manufactured by the pharmaceutical company Sinovac Biotech will arrive in the country packed. On the contrary, the biological manufactured by CanSino will arrive in bulk and It will be packaged in the state of Querétaro.

Until now, the repertoire of vaccines against COVID-19 in Mexico is made up of five. Those of CanSinoBio and Sinovac joined Pfizer-BioNTech, AstraZeneca and Sputnik V to be used in an emerging way.

There are already 169,760 confirmed deaths in Mexico from the new coronavirus (COVID-19). (Photo: Cuartoscuro)

There are already 169,760 confirmed deaths in Mexico from the new coronavirus (COVID-19). 

The COVID-19 vaccine from CanSinoBio showed an efficacy of 65.7% in the prevention of mild symptomatic cases, as well as 90.98% when faced with serious symptomatic pictures. For its part, Coronavac is 50.38 percent effective.

José Luis Alomía Zegarra, general director of Epidemiology of the Ministry of Health (SSa), reported that this February 10 there are already 169,760 deaths confirmed in Mexico due to the new coronavirus (COVID-19). In other words, in the last 24 hours there were 1,328 deaths.

From the National Palace, he pointed out that Mexico City and the State of Mexico are the entities with the highest number of active cases Estimates (with start date of the last 14 days by the positivity index, by entity and epidemiological week). At the national level 67,536 infections of this type are calculated.

In addition, there are more than 2,000 suspicious deaths that could add to the total in the next few hours. They also counted patients 1,519,527 recovered. On the other hand, they are recorded 84,592 people with a complete vaccination schedule (application of two doses of the Pfizer-BioNTech antigen).

According to the official, until this Wednesday there is a 47% of bed occupancy nationwide (both general care and fan).

Ben Oakley
Ben Oakley is the guy you can really trust when it comes to Mainstream News. Whether it is something happening at the Wall Street of New York City or inside the White House in Washington, D.C., no one can cover mainstream news like Ben. Get a daily dose of Trustworthy News by Ben Oakley, only at Globe Live Media.